Simvastatin
Simvastatin is a pharmaceutical drug with 323 clinical trials. Currently 9 active trials ongoing. Historical success rate of 89.8%.
Success Metrics
Based on 230 completed trials
Phase Distribution
Phase Distribution
85
Early Stage
63
Mid Stage
133
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.6%
230 of 272 finished
15.4%
42 ended early
9
trials recruiting
323
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
A Study of LY3502970 in Healthy Participants
Clinical Trials (323)
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
A Study of LY3502970 in Healthy Participants
Alveolar Ridge Splitting With Simvastatin/PRF Composite and Simultaneous Implant Placement
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Simvastatin in Secondary Progressive Multiple Sclerosis
Topic Simvastatin for Bone Regeneration
Randomized Double Blind Placebo Control Study in Patients with Schizophrenia
Multiple Sclerosis-Simvastatin Trial 2
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 323